Status:
UNKNOWN
Pain Modulation - Experimental Assessments Using Different Modalities
Lead Sponsor:
Schweinhardt Petra
Conditions:
Low Back Pain
Compare Pain Modulation Assessments in Pain-free Cohorts
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The goal of this study is to investigate how different painful stimuli are processed and modulated in the nervous system. In various pain conditions, including low back pain, often no specific source ...
Eligibility Criteria
Inclusion
- German or English proficiency
- Informed consent
- primary pain complaint localized between the 12th rib and the gluteal fold
- low back pain for more than one week
- low back pain clinically not attributable to "red flags" (including infection, trauma, fractures, inflammatory)
Exclusion
- unable to give informed consent (e.g. due to language problems)
- any neurological condition
- any major medical or psychiatric condition (e.g. severe heart disease, diabetes, autoimmune disorders, major depressive disorder), any chronic pain condition other than low back pain
- pregnancy
- Radiating pain below knee level (radicular pain)
Key Trial Info
Start Date :
May 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2025
Estimated Enrollment :
705 Patients enrolled
Trial Details
Trial ID
NCT04323293
Start Date
May 1 2019
End Date
May 31 2025
Last Update
April 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Balgrist University Hospital
Zurich, Switzerland, 8008